Immediate Impact

36 standout
Sub-graph 1 of 18

Citing Papers

A Self‐Amplifying ROS‐Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy
2024 Standout
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
2024 Standout
2 intermediate papers

Works of Teklu Legesse being referenced

Isolated Gastritis Secondary to Immune Checkpoint Inhibitors Complicated by Superimposed Cytomegalovirus Infection
2022
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance
2018

Author Peers

Author Last Decade Papers Cites
Teklu Legesse 35 43 71 76 50 23 298
Yutong Chen 18 32 43 19 98 18 311
Joo Ho Kim 38 25 76 25 36 30 289
Daniel Calva 26 64 104 75 40 15 325
Dorothee Dill‐Müller 12 133 50 145 27 23 331
Eric Liao 31 17 27 22 21 24 252
Angelica Selim 12 100 35 33 69 15 248
Yuji Asada 44 34 53 111 65 26 320
Patrick R. Boulos 8 41 83 46 50 20 301
Qingfeng Li 12 58 38 25 88 16 253
D. Friday King 25 26 93 101 27 22 283

All Works

Loading papers...

Rankless by CCL
2026